Perspective

Sullivan JL. Iron and sex difference in heart disease risk. Lancet 1981; i: 1293-1294.

Zacharski LR , Ornstein DL , Woloshin S , Schwartz LM. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 2000; 140: 98-104.

Zacharski LR , Chow B , Lavori PW et al. The iron (Fe) and atherosclerosis study (FeAST): a pilot study of reduction of body iron stores in atherosclerotic peripheral vascular disease. Am Heart J 2000; 139: 337-345.

Kiechl S , Willeit J , Egger G , Poewe W , Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997; 96: 3300-3307.

Kakhlon O , Cabantchik ZI. The labile iron pool: characterization, measurement, and participation in cellular processes. Free Radic Biol Med 2002; 33: 1037-1046.

Rasmussen ML , Folsom AR , Catellier DJ , Tsai MY , Garg U , Eckfeldt JH. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2001; 154: 739-746.

Gerhard GS , Kaufmann EJ , Wang X et al. Genetic differences in hepatic lipid peroxidation potential and iron levels in mice. Mech Ageing Dev 2002; 123: 167-176.

Bomford A. Genetics of haemochromatosis. Lancet 2002; 360: 1673-1681.

Salonen JT , Korpela H , Nyyssonen K et al. Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers. J Intern Med 1995; 237: 161-168.

Van Jaarsveld J , Pool GF. Beneficial effects of blood donation on high density lipoprotein concentration and the oxidative potential of low density lipoprotein. Atherosclerosis 2002; 16: 395-402.

Facchini FS , Saylor KL. Effect of iron depletion on cardiovascular risk factors. Studies in carbohydrate-intolerant patients. Ann N Y Acad Sci 2002; 967: 342-351.

Facchini FS , Hua NW , Stoohs RA. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 931-939.

Fernandez-Real JM , Penarroja G , Castro A , Garcia-Bragado F , Hernandez-Aguado I , Ricart W. Blood letting in high-ferritin type 2 diabetes. Effects on insulin sensitivity and b-cell function. Diabetes 2002; 51: 1000-1004.

Bofill C , Joven J , Bages J et al. Response to repeated phlebotomies in patients with non-insulin-dependent diabetes mellitus. Metabolism 1994; 43: 614-620.

Guillygomarc’h A , Mendler MH , Moirand R et al. Venesection therapy of insulin resistance-associated hepatic iron overload. J Hepatol 2001; 23: 344-349.

Duffy SJ , Biegelsen ES , Holbrook M , Russell JD , Gokce JK Jr. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 2001; 103: 2799-2804.

Failla M , Giannattasio C , Piperno A et al. Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy. Hepatology 2000; 1: 569-573.

Gaenzer H , Marschang P , Sturm W et al. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol 2002; 1: 2189-2194.

Meyers DG , Jensen KC , Menitove JE. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion 2002; 42: 1135-1139.

Grady D. Postmenopausal hormones - therapy for symptoms only. N Engl J Med 2003; 348: 1835-1837.